Results 101 to 110 of about 2,193 (158)

Multidrug-resistant tuberculosis (MDR-TB) in people living with HIV: Clinical issues, therapeutic challenges and perspectives in sub-Saharan Africa. A narrative review. [PDF]

J Clin Tuberc Other Mycobact Dis
Tague C.
europepmc   +1 more source

<i>In vitro</i> exposure to clofazimine can select for delamanid and pretomanid resistance in <i>Mycobacterium tuberculosis</i>. [PDF]

Antimicrob Agents Chemother
Rupasinghe P, Ismail N, Mulders W, Warren RM, Joseph L, Ngcamu D, Gwala T, Omar SV, Vereecken J, de Jong BC, Rigouts L, Borroni E, Cirillo DM, Schön T, Miotto P, Köser CU.   +15 more
europepmc   +1 more source

Drug-Resistant Tuberculous Meningitis (DR-TBM) in a Low-Incidence Setting: Two Cases and an Evidence Review Highlighting Key Advances and Knowledge Gaps in Clinical Management. [PDF]

Open Forum Infect Dis
Boschung KF, Wong PHP, Werry D, Sekirov I, Turvey SL, Cook VJ, Johnston J, Connors WJA.   +7 more
europepmc   +1 more source

Treatment outcomes and associated factors among patients with drug-resistant tuberculosis in Ethiopia: A retrospective cohort study. [PDF]

IJID Reg
Anito AA, Abdissa G, Gezahegn Y, Muhammed EU, Lemi H.   +4 more
europepmc   +1 more source

Management of adverse events in TB care and active TB drug safety monitoring. [PDF]

Breathe (Sheff)
Ma'aruf SY, Sharma A, Fox S, Duarte R, Lange C, Tiberi S.   +5 more
europepmc   +1 more source

Deconvoluting drug interactions using <i>M. tuberculosis</i> physiologic processes: transcriptional disaggregation of the BPaL regimen <i>in vivo</i>. [PDF]

Antimicrob Agents Chemother
Wynn EA, Dide-Agossou C, Al Mubarak R, Rossmassler K, Hendrix J, Voskuil MI, Obregón-Henao A, Lyons MA, Robertson GT, Moore CM, Walter ND.   +10 more
europepmc   +1 more source

Real-world safety profile of novel anti-multidrug-resistant tuberculosis drugs: a disproportionality analysis based on the FAERS database. [PDF]

BMJ Open
Zhao L, Zeng L, Qian Y, Zhao W, Xie R.
europepmc   +1 more source

Effectiveness of the Bedaquiline, Pretomanid, and Linezolid Regimen, With or Without Moxifloxacin, for Drug-Resistant Tuberculosis in Ukraine Under Programmatic Conditions. [PDF]

Clin Infect Dis
Dahl VN, Skouvig Pedersen O, Butova T, Kuzhko M, Raznatovska O, Fedorec A, Vekshyn V, Hlynenko V, Yevsiukova N, Hryshchuk L, Kornaha S, Chursina N, Kondratyuk N, Markovtsiy L, Skryp V, Bogomolov A, Klymenko T, Yankovska D, Ostrovskyy M, Makoida I, Levandovska D, Shpak Y, Didyk V, Siomak O, Butov D.   +24 more
europepmc   +1 more source

Cost-effectiveness of BPaL/BPaLM as compared to mixed standard of care bedaquiline containing regimen for MDR/RR-TB. [PDF]

Indian J Med Res
Muniyandi M, Nagarajan K, Chelvanayagam K, Rajsekar K, Tyagi K, Padmapriyadarsini C.   +5 more
europepmc   +1 more source